Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
Listen to The Bloodline with LLS
To subscribe to The Bloodline with LLS, click here.
Recent Episodes
Together in the Fight Against Chronic Myeloid Leukemia (CML): Roman Reigns’ Story
We will be speaking with WWE Superstar, actor, and former professional football player, Joseph Anoai, who many may know as Roman Reigns. Apart from fighting opponents in the ring, Roman found himself fighting his biggest opponent yet after receiving his leukemia diagnosis back in 2007. Listen as Roman Reigns explains his cancer journey to our very own President & CEO, Dr. Louis DeGennaro.
Dr. Ninan explains Diffuse Large B-cell Lymphoma (DLBCL)
Dr. Mary Ninan speaks to Alicia, Lizette, and Edith about the most common subtype of non-Hodgkin lymphoma (NHL), known as Diffuse Large B-cell lymphoma (DLBCL). With over 70 subtypes of NHL, the priority when Dr. Ninan sees a patient with lymphoma is to confirm which subtype the patient has been diagnosed with in order to determine the best treatment plan. Dr. Ninan explains how lymphoma is staged, and various treatment options are discussed. The doctor also mentions how she always encourages patients and caregivers to ask questions and clarify the points that they do not understand in the treatment plan, as well as welcomes questions about how patients can manage their side effects. Also, in this episode, Dr. Ninan talks about one of the most exciting developments in the treatment of diffuse large B-cell lymphoma in recent years.
Support for this episode provided by Epizyme, Genentech, Karyopharm, and Pharmacyclics/Janssen.
What Non-Hodgkin Lymphoma (NHL) Patients Should Know During the COVID-19 Pandemic
Has the Coronavirus (COVID-19) affected your non-Hodgkin lymphoma treatment? Join Alicia, Lizette and Edith as they speak with Dr. Lori Leslie about non-Hodgkin lymphoma and how patients have been receiving treatment during the coronavirus pandemic. Dr. Leslie is a part of the lymphoma division of the John Theurer Cancer Center in Hackensack NJ. She treats lymphoma and CLL clinically, is the director of the indolent lymphoma and CLL research programs and is heavily involved in the lymphoma CAR-T program. On this episode, Dr. Leslie explains the different types of lymphoma. The doctor informed us on how the coronavirus is affecting lymphoma patients, as well as if lymphoma patients should be taking any extra precautions at this time. Dr. Leslie also updated us about the latest news regarding a vaccine for the coronavirus. During this time, we remain hopeful after hearing Dr. Leslie say that research for lymphoma has continued despite the pandemic, and new treatments were recently approved for lymphoma patients.
Support for this episode provided by Epizyme, Genentech, Karyopharm, and Pharmacyclics/Janssen.
Creating Something Bigger Than Myself Despite Cancer: Brett Hagler’s Story
Join this conversation as Alicia, Edith and Lizette sit down to chat with Brett Hagler. Brett is an author, cancer survivor, and CEO of New Story, an organization that pioneers solutions to end global homelessness by working to create the world's first 3D-printed community. On this episode, Brett explains how his chondrosarcoma diagnosis helped to refine his focus and future goals, putting him on the path of creating something bigger than himself. Despite diagnosis, Brett challenges patients to reflect on the question, “How do I want to remember this moment 10 years from now?”, to help gather strength and purpose to push forward. He also describes the crucial role of caregivers and the importance of having a supportive community rallying around each person facing a serious illness.
Listen to The Bloodline with LLS
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.